Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Hydroxychloroquine may help delay skin damage in lupus patients.

Hair products don't affect lupus development or severity.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Most genetic mutations causing hypohidrotic ectodermal dysplasia in Russian patients are found in the EDA gene.

Understanding alopecia in Mexican adults helps create better, tailored treatments.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Pilonidal sinus disease is linked to more severe hidradenitis suppurativa.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand various diseases in older adults.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Many Chinese patients lose hair after weight loss surgery, especially women, and taking iron and zinc on their own doesn't help.

RCS-01 cell therapy is safe and improves skin gene expression.

Hair loss in lupus patients indicates higher disease activity.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Hair protein composition is similar across different races and shapes.

IsoPSA test works accurately even if patients take certain prostate medications.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

There is no significant link between metabolic syndrome and alopecia areata.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

Ixekizumab is safe for long-term use with low rates of major heart-related events.